More than half of clinically significant valvular heart disease is missed2. Now you can detect it earlier and more consistently, so your patients can get the treatment they need sooner.
Eko’s FDA-cleared platform3 is the first and only to identify structural murmurs with a digital stethoscope4.
SENSORA™ for structural murmur detection more than doubles the likelihood of detecting significant valvular heart disease1.
Care Pathway Analytics is designed to assist with critical decision-making by identifying care gaps within the patient's journey.
Deployment is quick and easy. The system is simple to use, requiring minimal training.
The stethoscope is already part of your clinical workflow. Eko’s detection works with your routine patient exam.
Eko’s dashboard gives you a comprehensive view of patients with structural murmurs to help you view and manage referrals.
Eko helps healthcare professionals detect heart and lung disease earlier and with higher accuracy, diagnose with more confidence, manage treatment effectively, and ultimately give patients the best care possible.
If you are at a hospital system in the US, contact us to learn how you can detect more valvular heart disease at your institution with Eko.
(1) Eko Murmur Analysis Software User Manual, LBL 295, Rev B. Structural murmur identification adult patients (>18 years old)
(2) d’Arcy et al. Eur Heart J 2016;37:3515–3522. doi:10.1093/eurheartj/ehw229
(3) FDA Clears Eko’s Heart Disease Detection AI for Adults and Pediatrics
(4) Contact Sales to learn more about SENSORA™
(5) Gardezi SKM, et al. Cardiac auscultation poorly predicts the presence of valvular heart disease in asymptomatic primary care patients, Heart 2018;104:1832–1835. doi:10.1136/heartjnl-2018-313082